Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 15, 2019 - Issue 7
Submit an article Journal homepage
172
Views
4
CrossRef citations to date
0
Altmetric
Perspective

Total threshold cytotoxicity of therapeutic antibodies for selective destruction of pathogenic memory T cells: implications for immunotherapy of autoimmune and allergenic disorders

Victor I. SeledtsovCenter for Medical Biotechnologies, lmmanuel Kant Baltic Federal University, Kaliningrad, RussiaCorrespondence[email protected]
View further author information
&
Galina V. SeledtsovaLaboratory for Cellular Technologies, Institute for Fundamental and Clinical Immunology, Novosibirsk, RussiaView further author information
Pages 701-706 | Received 12 Dec 2018, Accepted 08 May 2019, Published online: 24 May 2019

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Victor I. Seledtsov & Alexei von Delwig. (2021) Clinically feasible and prospective immunotherapeutic interventions in multidirectional comprehensive treatment of cancer. Expert Opinion on Biological Therapy 21:3, pages 323-342.
Read now

Articles from other publishers (3)

Victor Ivanovich Seledtsov, Galina V. Seledtsova & Alexei A. von Delwig. (2023) Immune-based, multifaceted inactivation of pathogenic T lymphocytes in treating autoimmune diseases. Exploration of Immunology, pages 506-512.
Crossref
Bo Liu, Rongfei Huang, Tingting Fu, Ping He, Chengyou Du, Wei Zhou, Ke Xu & Tao Ren. (2021) GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. PeerJ 9, pages e11423.
Crossref
Victor I. Seledtsov, Vladimir V. Malashchenko, Maksim E. Meniailo, Dmitriy N. Atochin, Galina V. Seledtsova & Igor A. Schepetkin. (2020) Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells. European Journal of Pharmacology 878, pages 173116.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.